We also observed that the DIM and Herceptin combination treatment resulted in significantly more cleaved PARP compared with mono-treatment (Fig. 2B), suggesting that the combination treatment could induce greater apoptosis in breast cancer cells, particularly in HER-2/neu expressed breast cancer cells. The gene discussed is ERBB2; the disease is breast carcinoma.